Journal
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Volume 1865, Issue 3, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbagen.2020.129828
Keywords
HsG6PD inhibition; Second-order inactivation constant; Inhibition type; Structural perturbation; Molecular docking
Categories
Funding
- E022 Program, National Institute of Pediatrics, Mexico City, Mexico (Recursos Fiscales para la Investigacion)
- INP [031/2018, 024/2017]
- CONACYT [259201]
- Catedras CONACYT [2184, 2057]
- [HIM/2017/100]
Ask authors/readers for more resources
In vitro studies identified two new compounds (CNZ-3 and JMM-2) as inhibitors of HsG6PD, showing different mechanisms of inhibition compared to previously known inhibitors. These compounds affect the protein's structure and thermal stability, highlighting their potential as future pharmacological approaches for cancer research and treatment.
Background: The pentose phosphate pathway (PPP) has received significant attention because of the role of NADPH and R-5-P in the maintenance of cancer cells, which are necessary for the synthesis of fatty acids and contribute to uncontrollable proliferation. The HsG6PD enzyme is the rate-limiting step in the oxidative branch of the PPP, leading to an increase in the expression levels in tumor cells; therefore, the protein has been proposed as a target for the development of new molecules for use in cancer. Methods: Through in vitro studies, we assayed the effects of 55 chemical compounds against recombinant HsG6PD. Here, we present the kinetic characterization of four new HsG6PD inhibitors as well as their functional and structural effects on the protein. Furthermore, molecular docking was performed to determine the interaction of the best hits with HsG6PD. Results: Four compounds, JMM-2, CCM-4, CNZ-3, and CNZ-7, were capable of reducing HsG6PD activity and showed noncompetitive and uncompetitive inhibition. Moreover, experiments using circular dichroism and fluorescence spectroscopy showed that the molecules affect the structure (secondary and tertiary) of the protein as well as its thermal stability. Computational docking analysis revealed that the interaction of the compounds with the protein does not occur at the active site. Conclusions: We identified two new compounds (CNZ-3 and JMM-2) capable of inhibiting HsG6PD that, compared to other previously known HsG6PD inhibitors, showed different mechanisms of inhibition. General significance: Screening of new inhibitors for HsG6PD with a future pharmacological approach for the study and treatment of cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available